Alcon takes another step towards WaveLight acquisition

Article

The German Federal Financial Supervisory Authority has approved publication of Alcon's tender offer document for WaveLight AG. This tender offer marks the second step in the completion of Alcon's acquisition of WaveLight.

The German Federal Financial Supervisory Authority has approved publication of Alcon's tender offer document for WaveLight AG. This tender offer marks the second step in the completion of Alcon's acquisition of WaveLight.

Alcon hopes to increase its stake in WaveLight from 16% of issued shares to at least 75% and, in response to recent trading activity, Alcon has increased its previously announced offer for WaveLight from €10 to €15 per share. The tender offer acceptance period closes on 11th September, 2007.

Alcon isn't the only firm to express an interest in WaveLight, however. Carl Zeiss Meditec has also acquired a 5% shareholding in the firm. The company says that the acquisition of stock demonstrates its interest in a possible voluntary takeover offer. Zeiss believes any takeover would be based on the future earning potential of Wavelight and the possible benefits that could arise from combining the two businesses.

On 20th August, WaveLight's Executive Committee and Supervisory Board recommended that shareholders tender their shares to Alcon.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.